terzepatide vs semaglutide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide vs Tirzepatide for Weight

ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression

BioXconomy recently reported on a landmark study that showed GLP-1s cut mortality and hospitalization rates from heart failure by 40%, potentially independent of their weight loss effects

If GLP-1 therapy fails to achieve individualised HbA1c targets, combination therapy is often the next step

The evidence base regarding GLP-1 receptor agonists in patients with inflammatory bowel disease, including Crohn's disease, remains limited but is an area of growing research interest

Amelioration of diabetes mellitus by modulation of GLP-1 via targeting alpha-glucosidase using Acacia tortilis polysaccharide in Streptozotocin-Nicotinamide induced diabetes in rats